Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Olson, Timothy S  [Clear All Filters]
2024
Oved JH, Gibson NM, Venella K, Elgarten CW, Wray L, Warren JT, Olson TS. Reduced toxicity matched sibling bone marrow transplant results in excellent outcomes for severe congenital neutropenia. Front Immunol. 2024;15:1369243.
2023
Anderson DS, Hanna RS, Azar AReza Pashm, Collier V, Hankins P, Loudon B, Olson TS, Grupp SA, Phillips CA, Kadauke S. Automation of Hematopoietic Cell Transplant Outcomes Reporting Leads to Dramatic Reduction of Errors Reported to Real-World Data Registry. Transplant Cell Ther. 2023.
Jain T, Olson TS, Locke FL. How I Treat Cytopenias after CAR T-cell Therapy. Blood. 2023.
2021
Marsh RA, Hebert K, Kim S, Dvorak CC, Aquino V, K Baker S, Chellapandian D, Saldana BDavila, Duncan C, Eckrich MJ, et al. A Comparison of Hematopoietic Cell Transplant Conditioning Regimens for Hemophagocytic Lymphohistiocytosis Disorders. J Allergy Clin Immunol. 2021.
Le Coz C, Nguyen DN, Su C, Nolan BE, Albrecht AV, Xhani S, Sun D, Demaree B, Pillarisetti P, Khanna C, et al. Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients. J Exp Med. 2021;218(7).
Holdreith N, Lee GY, Chandra V, Salinas CSalas, Nicholas P, Olson TS, Tong W. LNK (SH2B3) Inhibition Expands Healthy and Fanconi Anemia Human Hematopoietic Stem and Progenitor Cells. Blood Adv. 2021.
Leahy ABarz, Li Y, Talano J-A, Elgarten CW, Seif AE, Wang Y, Johnson B, Monos D, Kadauke S, Olson TS, et al. Unrelated donor α/β T-cell and B-cell-depleted HSCT for the treatment of pediatric acute leukemia. Blood Adv. 2021.
2019
Seif AE, Li Y, Monos DS, Heidemann SC, Aplenc R, Barrett DM, Casper JT, Freedman JL, Grupp SA, Margolis DA, et al. Partially CD3-depleted unrelated and haploidentical donor PSCT has favorable GVHD and survival rates in pediatric hematologic malignancy. Biol Blood Marrow Transplant. 2019.
2018
Oved JH, Wang Y, Barrett DM, Levy EM, Huang Y, Monos DS, Grupp SA, Bunin NJ, Olson TS. CD3/CD19 depleted matched and mismatched unrelated donor hematopoietic stem cell transplant with targeted T cell addback is associated with excellent outcomes in pediatric patients with non-malignant hematologic disorders. Biol Blood Marrow Transplant. 2018.
2013
Williams DA, Bennett C, Bertuch A, Bessler M, Coates T, Corey S, Dror Y, Huang J, Lipton J, Olson TS, et al. Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): An initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC). Pediatr Blood Cancer. 2013.